Institutional Ownership Relay Therapeutics, Inc. (RLAY)
This table provides information about the institutional ownership of Relay Therapeutics, Inc. (RLAY). We have compiled data on the 207 institutions that hold shares in the stock, with a total of 159 Million shares, which have been reported (via 13F filing form) to have a value of $623 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Sb Investment Advisers (Uk) LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
27,904,963
shares
|
$109 Million
1.01% of portfolio
|
Q3 2020
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
15,030,209
shares
|
$58.9 Million
0.0% of portfolio
|
Q4 2024
Added 3.92%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,542,667
shares
|
$41.3 Million
0.0% of portfolio
|
Q2 2024
Added 7.62%
|
|
|
Casdin Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
8,948,574
shares
|
$35.1 Million
3.17% of portfolio
|
Q4 2024
Reduced 3.27%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
8,068,058
shares
|
$31.6 Million
2.5% of portfolio
|
Q4 2024
Added 126.12%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
7,377,292
shares
|
$28.9 Million
0.61% of portfolio
|
Q4 2024
Added 0.0%
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
5,781,878
shares
|
$22.7 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
5,279,726
shares
|
$20.7 Million
0.0% of portfolio
|
Q4 2024
Added 22.78%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
4,978,443
shares
|
$19.5 Million
0.0% of portfolio
|
Q4 2024
Reduced 9.77%
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
3,846,409
shares
|
$15.1 Million
2.95% of portfolio
|
Q1 2024
Added 185.68%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,321,741
shares
|
$13 Million
0.0% of portfolio
|
Q4 2024
Reduced 37.09%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,030,157
shares
|
$11.9 Million
0.0% of portfolio
|
Q4 2024
Added 10.9%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
2,964,997
shares
|
$11.6 Million
0.0% of portfolio
|
Q4 2024
Added 69.56%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,705,969
shares
|
$10.6 Million
0.0% of portfolio
|
Q4 2024
Added 36.98%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,682,083
shares
|
$10.5 Million
0.21% of portfolio
|
Q3 2024
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
2,568,384
shares
|
$10.1 Million
0.01% of portfolio
|
Q4 2024
Added 142.39%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
2,268,825
shares
|
$8.89 Million
1.4% of portfolio
|
Q4 2024
Added 11.6%
|
|
|
Finepoint Capital LP
Boston, MA |
Feb 13, 2025 Q4 2024 |
2,175,646
shares
|
$8.53 Million
0.76% of portfolio
|
Q4 2024
Added 33.79%
|
|
|
Candriam S.C.A.
|
Feb 06, 2025 Q4 2024 |
1,729,199
shares
|
$6.78 Million
0.04% of portfolio
|
Q4 2024
Added 58.25%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
1,592,753
shares
|
$6.24 Million
0.02% of portfolio
|
Q4 2024
Added 18.03%
|
|
|
Alphabet Inc.
Mountain View, CA |
Feb 06, 2025 Q4 2024 |
1,568,753
shares
|
$6.15 Million
0.46% of portfolio
|
Q1 2022
Added 0.29%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,549,190
shares
|
$6.07 Million
0.01% of portfolio
|
Q4 2024
Added 130.85%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,400,000
shares
|
$5.49 Million
0.01% of portfolio
|
Q4 2024
Reduced 15.15%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,300,770
shares
|
$5.1 Million
0.0% of portfolio
|
Q4 2024
Added 35.2%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,169,979
shares
|
$4.59 Million
0.0% of portfolio
|
Q4 2024
Added 24.7%
|